Cerebral infarction
Pro Research Analysisby 
Searched over 200M research papers for "cerebral infarction"
Definition and Pathophysiology of Cerebral Infarction
Cerebral infarction, commonly known as stroke, occurs when blood flow to the brain is interrupted, leading to cell death due to prolonged ischemia. This can result from either a blockage or rupture of blood vessels, causing localized oxygen deprivation and subsequent damage to brain function. The most widely accepted definition now focuses on evidence of brain or retinal cell death caused by cerebral ischemia, aligning with modern diagnostic advances and harmonizing with definitions used in other organ systems like the heart 12.
Epidemiology and Public Health Impact
Cerebral infarction is a leading cause of disability and death worldwide, affecting both older adults and, increasingly, younger individuals. Recent data highlight a significant proportion of cases occurring in people aged 15-49, emphasizing the need for awareness and prevention efforts across all age groups. Cardiovascular diseases, including cerebral infarction, account for millions of deaths annually, making this a major global health concern 26.
Subtypes and Clinical Outcomes
Cerebral infarction can be classified into several subtypes based on the affected vascular territory:
- Total anterior circulation infarcts (TACI): Involve both cortical and subcortical regions, associated with high mortality and poor functional outcomes.
- Partial anterior circulation infarcts (PACI): More restricted, predominantly cortical, with a higher risk of early recurrent stroke.
- Posterior circulation infarcts (POCI): Affect the vertebrobasilar territory, with better chances of good recovery but risk of later recurrence.
- Lacunar infarcts (LACI): Small, deep infarcts that can still result in significant disability .
The natural history and prognosis vary by subtype, influencing treatment strategies and clinical trial design .
Special Populations: Young Adults and Perinatal Cases
In young adults, the causes and outcomes of cerebral infarction differ from those in older populations. About half of young patients have identifiable causes, often embolic and cardiac in origin, while hypertension is common in those aged 31-40. Many young survivors experience good recovery, but a significant portion have no clear etiology 26.
Perinatal cerebral infarction, often linked to asphyxia or intraventricular hemorrhage, is associated with high rates of neonatal seizures and poor outcomes, with most affected infants either dying or experiencing significant impairment .
Silent Cerebral Infarction
Silent cerebral infarctions (SCI) are brain lesions detected by imaging in individuals without clinical symptoms. These are particularly noted in conditions like sickle cell disease and are important because their presence predicts future risk of both silent and overt strokes .
Diagnostic Advances and Biomarkers
Modern diagnosis of cerebral infarction relies heavily on imaging techniques such as CT and MRI, which can detect both overt and silent infarcts. Newer non-invasive brain monitoring tools and biosensors are being developed, and research into biomarkers, including non-coding RNAs, is expanding the potential for early diagnosis and targeted therapy 47.
Pathophysiology and Infarct Growth
The progression of cerebral infarction depends on the rate at which hypoperfused but viable tissue (the ischemic penumbra) becomes irreversibly damaged. This infarct growth rate varies widely among patients and is influenced by factors like collateral blood flow and baseline health. Understanding these dynamics is crucial for acute treatment decisions and prognosis .
Delayed and Secondary Infarction
Delayed cerebral infarction can occur after events like aneurysmal subarachnoid hemorrhage, often leading to poor long-term outcomes. The size and location of these infarcts, especially in critical brain regions, are strongly associated with unfavorable recovery .
Neuroinflammation and Immune Response
After cerebral infarction, the brain undergoes a complex immune response involving both innate and adaptive mechanisms. This includes the release of inflammatory mediators, disruption of the blood-brain barrier, and infiltration of immune cells, which can worsen neurological deficits. Non-coding RNAs are emerging as important regulators of these processes and may serve as future biomarkers or therapeutic targets .
Conclusion
Cerebral infarction is a complex and heterogeneous condition with significant health impacts across all age groups. Advances in imaging, understanding of subtypes, and research into molecular biomarkers are improving diagnosis, prognosis, and treatment. Continued research and tailored prevention strategies are essential to reduce the global burden of this disease.
Sources and full results
Most relevant research papers on this topic